Cargando…
Current evidence of drug-elution therapy for infrapopliteal arterial disease
New and sophisticated endovascular devices, such as drug-eluting stents (DES) and drug-coated balloons (DCB), provide targeted drug delivery to affected vessels. The invention of these devices has made it possible to address the reparative cascade of arterial wall injury following balloon angioplast...
Autores principales: | Spiliopoulos, Stavros, Vasiniotis Kamarinos, Nikiforos, Brountzos, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354073/ https://www.ncbi.nlm.nih.gov/pubmed/30705739 http://dx.doi.org/10.4330/wjc.v11.i1.13 |
Ejemplares similares
-
Revisiting endovascular treatment in below-the-knee disease. Are drug-eluting stents the best option?
por: Spiliopoulos, Stavros, et al.
Publicado: (2018) -
Overcoming ischemia in the diabetic foot: Minimally invasive treatment options
por: Spiliopoulos, Stavros, et al.
Publicado: (2021) -
Meta-analysis of outcomes from drug-eluting stent implantation in infrapopliteal arteries
por: Li, Ming-Xuan, et al.
Publicado: (2023) -
Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art
por: Facciorusso, Antonio
Publicado: (2018) -
A universal drug delivery catheter for the treatment of infrapopliteal arterial disease using liquid therapy
por: Bunch, Frank, et al.
Publicado: (2020)